Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

86-13954187575

Jinan Hongyuan Chemical Co.,Ltd

모두
  • 모두
  • 표제
언어

Jinan Hongyuan Chemical Co.,Ltd

 [Shandong,China]

회사유형:무역 회사 , 제조사

주요 시장: 아프리카 , 미주 , 아시아 , 카리브 해 , 동유럽 , 유럽 , 중동 , 북유럽 , 오세아니아 , 기타 시장 , 서유럽 , 세계적인

수출업자:51% - 60%

인증서 표시:ISO9001, CE, GMP, HACCP, ISO14001, FDA, MSDS

홈페이지> 블로그> Preliminary Pharmaceuticals and Celsion reached a second cooperation to develop DNA vaccines

Preliminary Pharmaceuticals and Celsion reached a second cooperation to develop DNA vaccines

September 23, 2021
On September 22, Hainan Puli Pharmaceutical Co., Ltd. announced that it had recently signed a framework cooperation agreement on DNA vaccines with Celsion Corporation of the US biopharmaceutical. Commercial batch supply after approval.


The announcement stated that Puli Pharmaceuticals and Celsion have cooperated for many years and have established a successful cooperative relationship. This cooperation is the second cooperation between the company and Celsion after the first DNA new drug project cooperation. The first cooperation project between the two parties is GEN-1, which integrates the DNA plasmid encoding IL-12 into a unique nanoparticle delivery system. Celsion is conducting a phase I/II OVATION 2 trial, combining GEN-1 with chemotherapy to treat newly diagnosed advanced ovarian cancer. Puli Pharmaceuticals produced clinical batch samples for the study. DNA vaccines and mRNA vaccines are both nucleic acid vaccines, which are called "third-generation vaccine technology" in the industry. The principle of DNA vaccine is to make the DNA encoding the antigen protein into the vaccine, enter the human body and express the antigen in the body to induce the human body to produce an immune response, so that the vaccinators can obtain the corresponding immune protection ability, with rapid development and production, strong immunity, and safety The advantage is that it can be stored for a long time at room temperature.
이전
다음
문의하기

Author:

Ms. Yi

Phone/WhatsApp:

+8618888297294

인기 상품
뉴스
프로필렌 카보네이트 란 무엇입니까?

December 13, 2022

리포산은 무엇입니까?

December 06, 2022

산업 뉴스
타우린은 무엇에 사용됩니까?

November 16, 2022

수크랄로스는 무엇에 사용됩니까?

November 16, 2022

Blog News
Two new drugs are included in the proposed priority review varieties! From Hengrui Pharmaceutical, Jinsai Pharmaceutical

February 21, 2022

Qin Hao Pharmaceutical's new SHP2 inhibitor clinical trial application was approved in the U.S.

October 30, 2021

You may also like
Related Categories

이 업체에게 이메일로 보내기

제목:
이메일:
메시지:

Your message must be betwwen 20-8000 characters

문의하기

Author:

Ms. Yi

Phone/WhatsApp:

+8618888297294

인기 상품
뉴스
프로필렌 카보네이트 란 무엇입니까?

December 13, 2022

리포산은 무엇입니까?

December 06, 2022

산업 뉴스
타우린은 무엇에 사용됩니까?

November 16, 2022

수크랄로스는 무엇에 사용됩니까?

November 16, 2022

Blog News
Two new drugs are included in the proposed priority review varieties! From Hengrui Pharmaceutical, Jinsai Pharmaceutical

February 21, 2022

Qin Hao Pharmaceutical's new SHP2 inhibitor clinical trial application was approved in the U.S.

October 30, 2021

홈페이지

Product

Whatsapp

우리에 대해

문의
Please Leave Us A Message

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

첨부 파일 업로드
송신